U.S. market Closed. Opens in 1 day 9 hours 40 minutes

GTBP | GT Biopharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/A4.00K
Gross ProfitN/AN/AN/AN/A-4.00K
Operating Expenses13.58M21.26M57.52M6.76M11.46M
Selling, General & Admin7.11M12.45M47.92M6.28M9.79M
Research & Development6.47M8.81M9.59M485.00K1.67M
Other Operating ExpensesN/AN/A-242.76K-12.60MN/A
Operating Income-13.58M-21.26M-57.52M-6.76M-16.06M
Other Expenses / Income5.98M373.00K-498.00K-21.53M-22.59M
Before Tax Income-7.60M-20.88M-58.01M-28.30M-38.65M
Income Tax ExpensesN/A-381.00K680.00K3.32M2.13M
Net Income-7.60M-20.50M-58.69M-31.62M-40.77M
Interest ExpensesN/A8.00K718.00K3.32M2.13M
Basic Shares Outstanding1.35M1.06M938.52K146.17K112.80K
Diluted Shares Outstanding1.35M1.06M938.52K146.17K112.80K
EBITDA5.98MN/AN/A-24.98M-11.45M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-7.60M-20.88M-57.30M-24.98M-36.52M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙